NAD+ (Nicotinamide Adenine Dinucleotide) — Coenzyme Active for Cellular Anti-Aging in Cosmetics
Nicotinamide Adenine Dinucleotide in its oxidised form (NAD+) is a coenzyme present in every living cell, serving as the principal electron carrier in over 400 enzymatic redox reactions. In skin biology, NAD+ levels decline measurably with chronological age — dermal fibroblasts from donors aged 60+ contain roughly 50% less NAD+ than those from donors in their twenties. This depletion directly impacts sirtuin activity, PARP-mediated DNA repair capacity, and mitochondrial ATP output, all of which are central to the visible signs of skin aging. TCS NEXUS S.L. supplies cosmetic-grade NAD+ (≥98% enzymatic purity) from our warehouse in Valencia, Spain for formulators targeting the growing cellular-energy segment of the anti-aging market.
Technical Specifications
| Parameter | Value |
|---|---|
| INCI Name | NAD+ (Nicotinamide Adenine Dinucleotide, oxidised form) |
| CAS Number | 53-84-9 |
| Molecular Formula | C₂₁H₂₇N₇O₁₄P₂ |
| Molecular Weight | 663.43 g/mol |
| Purity | ≥ 98% (enzymatic assay) |
| Appearance | White to slightly yellow powder |
| Solubility | Water-soluble |
| Recommended pH | 5.0 – 7.0 |
| Dissolution Temperature | ≤ 45 °C |
| Recommended Use Level | 10 – 1000 ppm (0.001 – 0.1%) |
| Storage | –20 °C, sealed, protect from light and moisture |
Mechanism of Action
Coenzyme in Cellular Redox Reactions
NAD+ functions as a hydride acceptor in catabolic pathways — glycolysis, the tricarboxylic acid cycle, and fatty acid β-oxidation — where it is reduced to NADH. This NADH then donates electrons to Complex I of the mitochondrial electron transport chain, driving oxidative phosphorylation and ATP synthesis. In aged keratinocytes and fibroblasts, reduced NAD+/NADH ratios correlate with lower ATP availability, impaired protein synthesis, and compromised barrier lipid production. Topical supplementation of NAD+ is intended to restore this metabolic substrate at the cellular level.
Sirtuin Cofactor — SIRT1 and SIRT3 Activation
Sirtuins (SIRT1–SIRT7) are NAD+-dependent deacylases that regulate gene expression patterns associated with longevity, inflammation, and stress resistance. SIRT1, the best-characterised member, deacetylates transcription factors including FOXO3a and NF-κB, promoting antioxidant enzyme expression while suppressing pro-inflammatory cytokine production. SIRT3 localises to mitochondria and maintains the activity of superoxide dismutase 2 (SOD2), the primary mitochondrial antioxidant. Both enzymes are stoichiometrically dependent on NAD+ — one molecule of NAD+ is consumed per deacetylation cycle — meaning that NAD+ availability is rate-limiting for sirtuin function in aging skin.
PARP Substrate for DNA Repair
Poly(ADP-ribose) polymerases (PARPs), particularly PARP-1, use NAD+ as a substrate to synthesise ADP-ribose polymers at sites of DNA strand breaks. This poly(ADP-ribosyl)ation is an early step in the base excision repair pathway, which handles the majority of UV-induced and oxidative DNA damage in skin. In chronically photo-exposed skin, PARP hyperactivation can deplete cellular NAD+ pools, creating a vicious cycle in which repair capacity declines as damage accumulates. Providing exogenous NAD+ topically may help sustain PARP function without exhausting the endogenous pool.
Cosmetic Benefits
The functional consequences of restored NAD+ levels in skin are multi-directional. By supporting mitochondrial energy output, NAD+ supplementation enhances the biosynthetic capacity of fibroblasts — more ATP means more procollagen, elastin, and glycosaminoglycan synthesis. Sirtuin activation shifts the inflammatory balance toward resolution, reducing baseline redness and improving tolerance to environmental stressors. PARP-mediated DNA repair protects genomic integrity, which is particularly relevant for skin exposed to cumulative UV damage. At the epidermal level, improved keratinocyte metabolism translates to better ceramide and free fatty acid production, strengthening the lipid lamellae of the stratum corneum and reducing transepidermal water loss (TEWL).
In cosmetic efficacy studies, topical formulations containing NAD+ precursors and NAD+ itself have demonstrated improvements in skin texture, elasticity, and evenness of tone. NAD+ at 100–500 ppm in serum-type vehicles has shown measurable effects on barrier recovery in volunteer panels, with TEWL reductions of 15–20% over 4 weeks of twice-daily application.
Formulation Guidelines
NAD+ is freely water-soluble and should be dissolved in the aqueous phase of emulsions or used directly in aqueous serums, essences, and toners. Dissolve at or below 45 °C — higher temperatures accelerate hydrolytic cleavage of the glycosidic bond between nicotinamide and ADP-ribose, reducing potency. The working pH range is 5.0–7.0; below pH 4.5, acid-catalysed hydrolysis of the pyrophosphate bridge becomes significant, while above pH 7.5, the nicotinamide moiety becomes susceptible to base-catalysed degradation.
Recommended use levels are 10–1000 ppm (0.001–0.1%) depending on the application. Anti-aging serums targeting sirtuin activation typically use 100–500 ppm. Barrier-repair formulations may use 50–200 ppm in combination with ceramides and niacinamide. NAD+ is compatible with most standard cosmetic ingredients including hyaluronic acid, peptides (Argireline, Matrixyl), vitamin C derivatives (ascorbyl glucoside, SAP), and conventional preservative systems. Avoid direct combination with strong reducing agents (ascorbic acid at high concentration, glutathione) in the same phase, as these can reduce NAD+ to NADH, altering the intended bioactivity.
Stability Considerations
NAD+ is light-sensitive — the nicotinamide ring absorbs UV radiation and undergoes photodegradation. Finished products should be packaged in opaque or amber containers. Accelerated stability testing at 40 °C / 75% RH shows that NAD+ retains >90% potency over 3 months when formulated at pH 5.5–6.5 and stored away from light. Chelating agents such as disodium EDTA (0.05–0.1%) improve stability by sequestering trace metals that catalyse oxidative degradation. For maximum shelf life, store raw material at –20 °C in sealed, desiccated containers.
Regulatory Context
NAD+ (CAS 53-84-9) is used as a cosmetic ingredient within the EU under Regulation (EC) No. 1223/2009. It does not appear in the Annexes of restricted or prohibited substances. As with all cosmetic ingredients placed on the EU market, the safety assessment must be documented in the Product Information File (PIF) and the product notified through the CPNP portal before commercialisation. TCS NEXUS S.L., based in Valencia, Spain, supplies NAD+ with full documentation including Certificate of Analysis, MSDS, and specification sheets to support your regulatory dossier.
Supply and Ordering
TCS NEXUS S.L. holds NAD+ in stock at our Valencia warehouse with standard European delivery in 5–7 business days. All shipments include a Certificate of Analysis with enzymatic purity data, moisture content, and heavy metal testing. Sample quantities are available for formulation development. Contact info@tcspeptides.com for pricing, bulk orders, or technical support.
Related Products
- Nicotinamide Mononucleotide (NMN) — NAD+ biosynthetic precursor via the salvage pathway
- Niacinamide (Vitamin B3) — upstream NAD+ precursor with established anti-inflammatory and barrier-repair efficacy
- GHK-Cu (Copper Peptide) — complementary anti-aging active targeting collagen remodelling and antioxidant defence
Further reading: See also: Cosmetic Peptides Technical Guide | Anti-Aging Peptide Comparison
Frequently Asked Questions
What is the difference between NAD+ and niacinamide in cosmetics?
Niacinamide (vitamin B3) is a biosynthetic precursor that cells convert into NAD+ through the salvage pathway via nicotinamide phosphoribosyltransferase (NAMPT). This conversion is rate-limited by NAMPT activity, which declines with age. NAD+ itself bypasses this enzymatic bottleneck, delivering the functional coenzyme directly. In practice, niacinamide works well at 2–5% concentration for barrier support and sebum regulation, while NAD+ targets the sirtuin/PARP axis more directly at much lower use levels (0.001–0.1%). The two are complementary rather than redundant and can be combined in the same formulation.
Can NAD+ penetrate the skin barrier?
NAD+ has a molecular weight of 663.43 Da, which is above the traditional 500 Da guideline for passive transdermal diffusion. However, the stratum corneum is not an absolute molecular-weight cutoff — hydrophilic molecules can traverse via appendageal routes (hair follicles, sweat glands) and through transient aqueous pores. Formulation strategies such as encapsulation in liposomes or niosomes, penetration enhancers (ethoxydiglycol, propanediol), and micro-emulsion vehicles can significantly enhance delivery to viable epidermis. Published permeation studies confirm detectable NAD+ delivery to the dermal-epidermal junction with optimised vehicle systems.
Is NAD+ stable in water-based formulations?
NAD+ is hydrolytically sensitive. At pH 5.5–6.5 and storage below 25 °C, aqueous solutions retain >90% potency for 3 months. Outside this pH range, degradation accelerates substantially. Light exposure is the other primary stability concern — always use opaque packaging. For maximum stability, formulate at pH 6.0, include a chelating agent (disodium EDTA at 0.05%), and package in airless pump containers with UV-protective walls. Lyophilised raw material stored at –20 °C has a shelf life exceeding 24 months.
What is the minimum order quantity?
TCS NEXUS S.L. offers NAD+ with no fixed MOQ for evaluation and formulation trial quantities. Production orders typically start at 100 g due to the high activity of the raw material. Contact our Valencia team at info@tcspeptides.com for sample requests, custom packaging, or volume pricing.
Technical Support and Samples
Request COA documents, sample availability, or support for custom synthesis.